Ken Ichi Masuda News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The arrival of COVID-19 in Japan in early 2020 prompted a concerted research effort at RIKEN. A strong research capacity in immunology, molecular biology.

Tomohiro morioKazuo kitauraRikiya watanabeShigeo koyasuKeio university school of medicineJapanese society for immunologyMolecular physiology laboratoryProgram for drug discoveryTechnology platformsIntegrative medical sciencesInternational union of immunological societiesMolecular biology society of japanHarvard universityUniversity of tokyoVaccine innovation laboratoryFederation of immunological societies asia